Current Activities

  • UEG X MNIBD: Best of UEG Week 2022

    This Twitter-hosted, video-based activity will highlight the top 10 IBD-focused abstracts presented at UEG Week 2022.

  • Short Bowel Syndrome - Consult with the Expert - Optimizing Care of SBS

    This CME-certified, Twitter-based video Consult with the Expert, will focus on medical management for both adult and pediatric patients with SBS.

  • Crohn's Perianal Fistula - Webinar #2

    This CME-certified, webinar will focus on initial and multidisciplinary management of Crohn’s perianal fistula (CPF), management of complex CPF after biologic failure (particularly the use of Mesenchymal stem cells), and conclude with a dedicated portion on the patient perspective.

  • Short Bowel Syndrome - Case Convo #2

    This CME-certified, MondayNightIBD Case Conversation will address care of an young adult patient SBS. The program moderator and co-moderator, in partnership with #MondayNightIBD will host an online Twitter Chat to review diagnostic and management options.

  • Therapeutic Approaches for Hospitalized Patients with COVID-19 - Tweetorial #1: Severity Assessments

    This CME-certified, Tweetorial reviews the latest clinical guidance regarding severity assessments and informs HCPs of staging options for hospitalized patients with COVID-19.

  • Short Bowel Syndrome Tweetorial #3 - Multidisciplinary Team

    This CME-certified, Tweetorial will focus on the importance of the multidisciplinary team for patients with SBS.

  • Hospitalized Patients with COVID-19 - Crack-the-Case #1

    Test your knowledge in the management of hospitalized patients with SARS-CoV-2 infection. This sequential series starts on Day One when you’re presented with a patient. Can you appropriately manage this patient…
    🏥 70y/o pt in the ED, 100.5*F, several days of dry cough, tingling in extremities for 2d
    💉Vaccinated, booster 9m ago. Experiences clinical deterioration: 100.8*F, O2 drops from 96% → 90% on room air, w/ worsening SOB

    Test yourself, and on Day Two, hear Dr. Ogbuagu discuss best practices in testing and management of moderate-to-severe COVID in the hospitalized patient.

  • Hospitalized Patients with COVID-19 - Tweetorial #2: Approved Therapies

    This CME-certified Tweetorial presents evidence supporting the use of FDA approved therapies for the patient hospitalized with COVID-19.

  • Hospitalized Patients w/ COVID-19 - Crack-the-Case #2

    Test your knowledge in the management of critically-ill patients with SARS-CoV-2 infection. This sequential series starts on Day One when you’re presented with a patient. Can you appropriately manage this patient…

    🏥 51y/o M SOT pt, admitted to the medical ward with acute kidney injury. His 02 requirements steadily increase and he is now admitted to the ICU.

    Test yourself, and on Day Two, hear Dr. Qadir discuss best practices in supportive care and therapeutic management of critically-ill patients with COVID..

  • Hospitalized Patients w/ COVID-19 - Tweetorial #3: At-Risk Populations

    This CME-certified, Tweetorial reviews the latest clinical guidance for populations with COVID-19 at-risk of poor outcomes.

  • Hospitalized Patients w/ COVID-19 - Crack-the-Case #3

    Are you up to the test in the management of hospitalized patients w SARS-CoV-2 infection? Can you appropriately manage this patient…

    🏥 67y/o M pt w/ multiple comorbidities & COVID. 👀 under surveillance in observation unit. 💨O2 requirements go from 1-2L to 4-5L over a 24hr period. ⏭️ admitted to med unit, what tx & supportive care to consider now?

    Test yourself, and on Day Two, hear Dr. Wray discuss best practices in supportive care and therapeutic management of patients with COVID and multiple co-morbid conditions.

  • Outpatient Care of Patients w/ COVID-19 - Tweetorial #1

    The goal of this proposed Tweetorial is to improve the familiarity of health care practitioners (HCPs) regarding risk factors associated with disease progression for patients with mild-to-moderate COVID-19 and the evidence regarding disparities in care as well as strategies to overcome them.

  • Driving Home the Differences Between CARs & Bispecific Antibodies: Tweetorial #1

    Determining appropriate treatment for multiple myeloma (MM) is complex due to the heterogeneity of the patient population, the occurrence of multiple disease relapses and the availability of multiple treatment options.

    This Twitter-based Tweetorial will explore the the differences between bispecific antibodies and CARs for the treatment of patients with MM.

  • #ShortBowelSyndrome Consult w/ the Expert #3

    Join Dr. Aline Charabaty, in a Transatlantic discussion focused on optimized management of patients with SBS with Dr. Valeria Cohran and Dr. Simon Gabe.

  • Real-world Access to T cell-directed Therapies in Multiple Myeloma: Driving Away Health Disparities | Tweetorial #2

    Despite advances in the treatment for multiple myeloma (MM), significant disparities exist for African American patients diagnosed with Multiple Myeloma.

    This Twitter-based Tweetorial will explore disparities and potential strategies to inequities in the management of patients with MM.

  • Best Practice for Providing T-cell Therapies in Multiple Myeloma | Tweetorial #3

    This X-based Tweetorial seeks to provide HCPs with best practices in the provision of T-cell therapies for patients with RRMM.

  • Acute Toxicities w/ BCMA-directed Therapies in Multiple Myeloma | Tweetorial #4

    Understanding the underlying mechanisms of toxicity of BCMA-directed therapies in patients with MM is critical to appropriate use of these therapies.

    This Twitter-based Tweetorial will explore the safety of BCMA-directed therapies for MM, as well as best practices to manage acute toxicities associated with these agents.

  • Delayed Toxicities w/ BCMA-directed Therapies in Multiple Myeloma | Tweetorial #5

    Understanding the underlying mechanisms of toxicity of BCMA-directed therapies in patients with MM is critical to appropriate use of these therapies.

    This Twitter-based Tweetorial will explore the safety of BCMA-directed therapies for MM, as well as best practices to manage delayed toxicities associated with these agents.

  • COVID Outpatient: Smarter in Minutes #3 ~ Paxlovid

    The goal of this proposed educational initiative is to improve the familiarity of health care practitioners (HCPs) with the evidence supporting the use of antivirals in the outpatient setting. This short, Smarter in Minutes episode focuses key considerations for Paxlovid in the treatment of COVID-19.

  • COVID Outpatient: Smarter in Minutes #4 ~ Remdesivir

    The goal of this proposed educational initiative is to improve the familiarity of health care practitioners (HCPs) with the evidence supporting the use of antivirals in the outpatient setting. This short, Smarter in Minutes episode focuses key considerations for remdesivir in the treatment of COVID-19.

  • COVID Outpatient: Smarter in Minutes #5 ~ Molnupiravir

    The goal of this proposed educational initiative is to improve the familiarity of health care practitioners (HCPs) with the evidence supporting the use of antivirals in the outpatient setting. This short, Smarter in Minutes episode focuses key considerations for molnupiravir in the treatment of COVID-19.

  • Expert Consult: Selecting BCMA- and GPRC5D-directed Therapies

    This video-based Expert Consult will explore the efficacy and safety data as well as clinical utility of approved BCMA- and GPRC5D-directed bispecific antibodies and BCMA-directed CAR-T call therapies for the treatment of RRMM.

  • COVID Outpatient: Smarter in Minutes #6 ~ Long COVID

    This short, Smarter in Minutes episode focuses key considerations for diagnosis, management, and research initiatives for Long COVID.

  • Short Bowel Syndrome Patient Case Game

    Short bowel syndrome (SBS) is a complex clinical condition that occurs from reduced or loss of intestinal absorption. With multiple treatment modalities available, combined with the unique challenges associated with this condition, it is becoming increasingly understood that patients with SBS are best managed under a model of coordinated care.

    This CME-certified, patient case game will allow learners to navigate the care of a fictional patient with SBS. As clinical decisions are made, feedback will be given to guide you in providing optimal care.